Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 44, 4962-4966, November 1, 1984]
© 1984 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cesario, T. C.
Right arrow Articles by Gorse, G. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cesario, T. C.
Right arrow Articles by Gorse, G. J.

Effect of Antineoplastic Agents on {gamma}-Interferon Production in Human Peripheral Blood Mononuclear Cells1

Thomas C. Cesario2, L. M. Slater, H. S. Kaplan, S. Gupta and G. J. Gorse

Divisions of Infectious Diseases [T. C. C.], Hematology [L. M. S.], and Immunology [S. G.], Department of Medicine, University of California Irvine, Orange, California 92668; Division of Infectious Diseases, Department of Medicine, Marshall University, Huntington, West Virginia 25701 [G. J. G.]; and American Red Cross, Orange County California Division, Santa Ana, California 92705 [H. S. K.]

Since {gamma}-interferon (IFN-{gamma}) is a potent immunomodulator and patients receiving certain antineoplastic agents are at risk of unusual infections, we have determined the effect of certain antineoplastic agents on IFN-{gamma} production. Induction of peripheral blood mononuclear cells from normal donors in the presence and absence of various antineoplastic agents was achieved using phytohemagglutinin (8 µg/ml). Supermatants were then separated by centrifugation, dialyzed, and assayed for interferon. Cell viability was always greater than 85% with or without the presence of drugs. Hydrocortisone was found to eliminate IFN-{gamma} production if added within 24 hr after the phytohemagglutinin. The suppression of IFN-{gamma} production occurred with hydrocortisone concentrations as low as 0.65 µg/ml, was associated with a diminished proliferative response to the lectin, and occurred with other interferon inducers including staphylococcal enterotoxin A.

Adriamycin (0.4 µg/ml) and vincristine (0.08 µg/ml) also diminished IFN-{gamma} production, but only if the peripheral blood mononuclear cells were pretreated with the drugs.

Methotrexate, 5-fluorouracil, and 6-mercaptopurine failed to influence the yield of IFN-{gamma}.

These results are significantly different from experiments previously reported using {alpha}- and ß-interferons and suggest an important mechanism by which these drugs can produce immunosuppression.

1 This research was supported by a grant from the KROC Foundation and a grant from the Alaska Cancer Research Telethon through the American Cancer Society.

2 To whom requests for reprints should be addressed, at Department of Medicine, University of California Irvine Medical Center, 101 City Drive South, Orange, CA 92668.

Received 4/ 9/84. Accepted 7/31/84.




This article has been cited by other articles:


Home page
Circ. Res.Home page
T. Uwatoku, H. Shimokawa, K. Abe, Y. Matsumoto, T. Hattori, K. Oi, T. Matsuda, K. Kataoka, and A. Takeshita
Application of Nanoparticle Technology for the Prevention of Restenosis After Balloon Injury in Rats
Circ. Res., April 18, 2003; 92 (7): e62 - e69.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1984 by the American Association for Cancer Research.